The FDA has approved use of GlaxoSmithKline’s Boostrix (Tdap) vaccine for use during the third trimester of pregnancy, for prevention of pertussis (whooping cough) in infants younger than two months ...
Portrait of young happy pregnant woman standing by the window Effectiveness in preventing pertussis among infants younger than 2 months of age when administered during the third trimester of pregnancy ...
PHILADELPHIA, PA, May 3, 2005 – GlaxoSmithKline (NYSE: GSK) today announced that its booster vaccine, Boostrix® [Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results